Philips Warms To Hypothermia Therapy Marketer InnerCool
This article was originally published in The Gray Sheet
Executive Summary
Philips Healthcare aims to boost its presence in the emergency care market by adding body temperature management device maker InnerCool Therapies to its Clinical Care Systems business
You may also be interested in...
Philips: InnerCool Stroke Trial Could Lead To $500 Mil. Market Opportunity
An international clinical trial using Philips Healthcare's InnerCool endovascular cooling technology to chill the brains of ischemic stroke patients will begin by the end of April
Philips: InnerCool Stroke Trial Could Lead To $500 Mil. Market Opportunity
An international clinical trial using Philips Healthcare's InnerCool endovascular cooling technology to chill the brains of ischemic stroke patients will begin by the end of April
Start-Up Quarterly Statistics, Q3 2009
Highlights from the Q3 2009 review of start-up dealmaking: Fundraising in the biopharma, medical device, and in vitro diagnostics industries totaled $520 million, a 40% decrease from the previous quarter and a 45% drop from Q3 2008. Of the total money raised in the current quarter, 64% or $333 million went to the biopharma companies. Compared with Q2 2009, device fundraising decreased by 76% (from $465 million to $113 million) but diagnostics companies raised significantly more--going from $23 million to $74 million. In contrast to the previous quarter, which saw only one acquisition, in Q3 2009 there were four involving start-ups, all of which are focusing on neurological disorders. On the alliance front, three companies--Oscient, NovaMed, and Ikaria Holdings--signed two deals each this quarter.